Kayne Anderson Rudnick Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $6.85M | Sell |
|
|||||
|
2023
Q2 | $44M | Sell |
|
|||||
|
2023
Q1 | $53.7M | Buy |
|
|||||
|
2022
Q4 | $71.4M | Sell |
|
|||||
|
2022
Q3 | $63.2M | Buy |
|
|||||
|
2022
Q2 | $49M | Buy |
|
|||||
|
2022
Q1 | $54.5M | Buy |
|
|||||
|
2021
Q4 | $54.5M | Sell |
|
|||||
|
2021
Q3 | $71.8M | Buy |
|
|||||
|
2021
Q2 | $61.5M | Buy |
|
|||||
|
2021
Q1 | $45.8M | Buy |
|
|||||
|
2020
Q4 | $54.9M | Buy |
|
|||||
|
2020
Q3 | $53.4M | Buy |
|
|||||
|
2020
Q2 | $18.9M | Buy |
|
|||||
|
2020
Q1 | $9.82M | Buy |
|
|||||
|
2019
Q4 | $9.07M | Buy |
|
|||||
|
2019
Q3 | $6.35M | Buy |
|
|||||
|
2019
Q2 | $6.94M | Buy |
|